Bionano Genomics, Inc.
BNGO- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001411690
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 20264:30 PM ET | Sep 4, 2026 | Luderer AlbertInterim Chief Executive | PPurchaseCommon Stock | +4K | $1.2112 | +$4.84K | 8K | +100.0% | SEC |
| Aug 21, 20264:30 PM ET | Aug 21, 2026 | Luderer AlbertInterim Chief Executive | PPurchaseCommon Stock | +4K | $1.215 | +$4.86K | 4K | New position | SEC |
| Jun 14, 2023 | Jun 13, 2023 | Mamuszka HannahDirector | PPurchaseCommon Stock | +65.79K | $0.76 | +$50K | 65.79K | New position | SEC |
| May 16, 2023 | May 16, 2023 | Holmlin R. ErikPresident and CEO | PPurchaseCommon Stock | +15K | $0.64 | +$9.6K | 806.47K | +1.9% | SEC |
| May 16, 2023 | May 12, 2023 | Stewart Christopher P.Chief Financial Officer | PPurchaseCommon Stock | +50K | $0.67 | +$33.5K | 281.37K | +21.6% | SEC |
| Aug 17, 20225:55 PM ET | Aug 15, 2022 | Linney YvonneDirector | SSaleCommon Stock | −20K | $3.6201 | −$72.4K | 0 | −100.0% | SEC |
| May 18, 2022 | May 16, 2022 | BARKER DAVID LDirector | PPurchaseCommon Stock | +10K | $1.60 | +$16K | 13.89K | +256.8% | SEC |
| Dec 1, 2021 | Nov 29, 2021 | Holmlin R. ErikPresident and CEO | PPurchaseCommon Stock | +5.03K | $3.9897 | +$20.05K | 5.03K | New position | SEC |